Case Reports
25 November 2015
Vol. 80 No. 1 (2013): Cardiac series
https://doi.org/10.4081/monaldi.2013.91

Tamoxifen treatment and pulmunary embolism: a case report and literature review

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
thrombosis, tamoxifen, pulmunary embolism
1268
Views
1312
Downloads

Authors

Gregoriana Zanini
gregoriana.zanini@aod.it
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
Benedetta Fontanella
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
Marco Racheli
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
Monica Bortolotti
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
Gianfranco Pasini
U.O. C. Cardiologia/UTIC, Ospedale La Memoria di Gavardo (Brescia), Italy.
Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



“Tamoxifen Treatment and Pulmunary Embolism: A Case Report and Literature Review”. 2015. Monaldi Archives for Chest Disease 80 (1). https://doi.org/10.4081/monaldi.2013.91.